DGX Gets NY Approval
Quest Diagnostics receives New York's Department of Health's approval for its Haystack Minimal Residual Disease liquid biopsy test
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Quest Diagnostics receives New York's Department of Health's approval for its Haystack Minimal Residual Disease liquid biopsy test